v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities    
Net loss $ (11,522) $ (46,150)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 890 957
Depreciation 2 2
Fair value change in warrant liabilities 0 33,829
Non-cash share settlement with investors 0 1,614
Unrealized loss from short-term investments 93 0
Change in assets and liabilities:    
Collaborations receivable 0 (50)
Prepaid expenses and other assets 574 313
Accounts payable 302 161
Accrued and other liabilities (318) (816)
Net cash used in operating activities (9,979) (10,140)
Investing activities    
Net cash used in investing activities 0 0
Financing activities    
Proceeds from issuance of common stock - registered direct offering 0 15,000
Proceeds from issuance of common stock - at-the-market program 3,066 4,067
Issuance costs (85) (1,102)
Payments in connection with short-term loan (538) 0
Exercise of stock options 27 10
Net cash provided by financing activities 2,470 17,975
Net (decrease) increase in cash and cash equivalents (7,509) 7,835
Cash and cash equivalents at beginning of period 24,534 16,399
Cash and cash equivalents at end of period 17,025 24,234
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 0 0
Cash paid for interest 9 0
Supplemental non-cash financing transactions:    
Non-cash reclassification of Series A warrant liability to equity 0 61,793
Unpaid issuance and deferred offering costs $ 3 $ 169

Source